Alice T Shaw - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Alice T Shaw

Showing results (61-70 of 204) with videos related to

Pageof 21

Sort By:

Lung Cancer (Amsterdam, Netherlands)|February 11, 2026

Combination therapy with lorlatinib and mitogen-activated protein kinase pathway inhibition in previously treated ALK- or ROS1-rearranged lung cancerJaime L Schneider, Alona Muzikansky, Elizabeth Krueger, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 5, 2016

Alectinib Dose Escalation Reinduces Central Nervous System Responses in Patients with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer Relapsing on Standard Dose AlectinibJustin F Gainor, Andrew S Chi, Jennifer Logan, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 13, 2019

ALK Mutation Status Before and After Alectinib Treatment in Locally Advanced or Metastatic ALK-Positive NSCLC: Pooled Analysis of Two Prospective TrialsJohannes Noé, Alex Lovejoy, Sai-Hong Ignatius Ou, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 21, 2019

Expediting Comprehensive Molecular Analysis to Optimize Initial Treatment of Lung Cancer Patients With Minimal Smoking HistoryIbiayi Dagogo-Jack, Hayley Robinson, Mari Mino-Kenudson, et al.

Blood|September 5, 2015

Ceritinib in patients with advanced anaplastic lymphoma kinase-rearranged anaplastic large-cell lymphomaHeike Richly, Tae Min Kim, Martin Schuler, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 19, 2016

Dramatic Response to Combination Erlotinib and Crizotinib in a Patient with Advanced, EGFR-Mutant Lung Cancer Harboring De Novo MET AmplificationJustin F Gainor, Matthew J Niederst, Jochen K Lennerz, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 11, 2011

Selective killing of K-ras mutant cancer cells by small molecule inducers of oxidative stressAlice T Shaw, Monte M Winslow, Margaret Magendantz, et al.

JTO Clinical and Research Reports|September 30, 2021

Efficacy of Taletrectinib (AB-106/DS-6051b) in ROS1+ NSCLC: An Updated Pooled Analysis of U.S. and Japan Phase 1 StudiesSai-Hong Ignatius Ou, Yutaka Fujiwara, Alice T Shaw, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2014

Patient-reported outcomes and quality of life in PROFILE 1007: a randomized trial of crizotinib compared with chemotherapy in previously treated patients with ALK-positive advanced non-small-cell lung cancerFiona Blackhall, Dong-Wan Kim, Benjamin Besse, et al.

Cancers|March 19, 2020

Imaging Features and Patterns of Metastasis in Non-Small Cell Lung Cancer with RET RearrangementsSubba R Digumarthy, Dexter P Mendoza, Jessica J Lin, et al.

Pageof 21

Search research articles

Showing results (61-70 of 204) with videos related to

Sort By:

Pageof 21

Lung Cancer (Amsterdam, Netherlands)|February 11, 2026

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 5, 2016

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 13, 2019

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 21, 2019

Expediting Comprehensive Molecular Analysis to Optimize Initial Treatment of Lung Cancer Patients With Minimal Smoking HistoryIbiayi Dagogo-Jack, Hayley Robinson, Mari Mino-Kenudson, et al.

Blood|September 5, 2015

Ceritinib in patients with advanced anaplastic lymphoma kinase-rearranged anaplastic large-cell lymphomaHeike Richly, Tae Min Kim, Martin Schuler, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 19, 2016

Proceedings of the National Academy of Sciences of the United States of America|May 11, 2011

Selective killing of K-ras mutant cancer cells by small molecule inducers of oxidative stressAlice T Shaw, Monte M Winslow, Margaret Magendantz, et al.

JTO Clinical and Research Reports|September 30, 2021

Efficacy of Taletrectinib (AB-106/DS-6051b) in ROS1+ NSCLC: An Updated Pooled Analysis of U.S. and Japan Phase 1 StudiesSai-Hong Ignatius Ou, Yutaka Fujiwara, Alice T Shaw, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2014

Cancers|March 19, 2020

Imaging Features and Patterns of Metastasis in Non-Small Cell Lung Cancer with RET RearrangementsSubba R Digumarthy, Dexter P Mendoza, Jessica J Lin, et al.

Pageof 21